RESEARCH TRIANGLE PARK, N.C. — The U.S. Food and Drug Administration has granted its approval for the winder use of the
GlaxoSmithKline
asthma drug known as Flovent HFA.
Flovent can now be prescribed for children ages 4 to 11, GSK said Thursday.
Some 3.6 million children ages 5-11 have asthma, according to federal health statistics cited by GSK.
Flovent was approved for use for patients ages 12 and older in 2004.



![[SLIDESHOW]](http://wwwcache.wral.com/asset/share/2012/02/09/10711513/4f348e7981bb5-51x75.jpg)
![[SLIDESHOW]](http://wwwcache.wral.com/asset/entertainment/out_and_about/2012/02/04/10712136/pics_agunn53833-100x75.jpg)
![[SLIDESHOW]](http://wwwcache.wral.com/asset/entertainment/2012/02/11/10719067/10719072-1329050037-100x75.jpg)
![[SLIDESHOW]](http://wwwcache.highschoolot.com/asset/content/2012/02/11/10717011/10717011-1328936455-100x75.jpg)
![[SLIDESHOW]](http://wwwcache.highschoolot.com/asset/content/2012/02/11/10717059/10717059-1328939591-100x75.jpg)







WRAL.com welcomes your comments on this story. All comments are moderated prior to publication based on our posting guidelines. Please review them prior to posting and if your message is not approved.
This story is closed for comments. Comments on WRAL.com news stories are accepted and moderated between the hours of 8 a.m. and 8 p.m. Monday through Friday.